Thomas has been serial entrepreneur for more than 30 years, 25 of which across the entire Life Sciences value chain. A relentless enthusiast by nature, he consistently dreams big, aims high and innovates across boundaries. He has taken many healthcare products and businesses from ideation all the way to the market, as well as subsequent successful divestiture and now heads up Neem Biotech as an innovation and incubation engine for an ever growing portfolio of groundbreaking therapeutic solutions. Shepherding game-changing opportunities that change world health for the better in unique ways is a lifelong dream come true for Thomas. It’s the perfect set-up for someone who dreams as big as he does.
Dr Nichols has spent 25 years at AstraZeneca in anti-infective drug discovery and development roles. He was formerly Director of Development Microbiology for the global phase III ceftazidime-avibactam development project and previously held directorships of the Microbiology and Development Microbiology departments at AstraZeneca.
Flic Gabbay is a pharmaceutical physician who has led numerous MAAs, NDAs and translational projects for infectious disease, respiratory and autoimmune programmes, including 10 recent antibiotic registrations. She held senior clinical development and Board roles in big pharma with global remits for over 10. She is also a committed entrepreneur, having started, led and raised substantial investment for several biotechnology companies and also service companies. She was founder chair of the Royal College of Physicians (UK) working party to set up the Faculty of Pharmaceutical Medicine in 1989 and currently is its Vice President.